RX-100

N/A

Report date: 2025/01/26 15:13:41
NME

Base Information

Drug NameRX-100
Drug Alias NameOral radioprotectant (RxBio)Subcutaneous radioprotectant (RxBio)Subcutaneous radioprotectant (RxBio)Oral radioprotectant (RxBio)RX-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionType 2 Lysophosphatidic Acid Receptor agonistsLysophosphatidic acid receptor Edg-7 agonistsLysophosphatidic acid receptor Edg-2 agonists
TargetsLysophosphatidic acid receptor Edg-2Type 2 Lysophosphatidic Acid ReceptorLysophosphatidic acid receptor Edg-7
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingRadiation sicknessDiarrhea +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRxBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRxBio Inc
Inactive CompaniesN/A
Active IndicationsRadiation sicknessDiarrheaStomach Ulcer
Inactive IndicationsChemotherapy-induced nausea and vomiting

Other Information

ATC CodeN/A
Related LinksN/A